StonvexLoading…
StonvexCore line items from GCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-29 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|---|
Revenue | $479.75M | $2.44B | $1.64B | $1.02B | $473.97M |
Operating Income | Not available | $17.31M | $-34.01M | $-42.59M | $-28.14M |
Net Income | Not available | $13.27M | $-34.34M | $-18.47M | $-21.23M |
EPS (Diluted) | $-2.59 | $1.25 | $-3.31 | $-3.82 | $-2.02 |
Total Assets | Not available | $1.39B | $1.47B | $1.42B | $1.40B |
Total Liabilities | Not available | $825.93M | $958.33M | $915.55M | $882.36M |
Cash & Equivalents | Not available | $105.41M | $27.03M | $40.99M | $21.75M |
Free Cash Flow OCF − CapEx | Not available | $83.71M | $-79.78M | $-48.27M | $-119.93M |
Shares Outstanding | Not available | 10.62M | 10.37M | 10.39M | 10.49M |